Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ion Beam ApplicationsIOBCF 82 Days Sales Outstanding is 48.82 as of Dec. 2025, which is 49% below its 10-year median of 96.25. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.67 (Fairly Valued). The stock has 9 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 72.22% on this metric.
The historical rank and industry rank for Ion Beam Applications's Days Sales Outstanding or its related term are showing as below:
IOBCF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.3 Med: 96.25 Max: 140
Current: 49.3
During the past 13 years, Ion Beam Applications's highest Days Sales Outstanding was 140.00. The lowest was 49.30. And the median was 96.25.
IOBCF's Days Sales Outstanding is ranked better than 72.22% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.85
vs IOBCF: 49.30
Ion Beam Applications's Days Sales Outstanding
declined
from Dec. 2024 (63.96) to Dec. 2025 (48.82).
Ion Beam Applications (OTCPK:IOBCF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Ion Beam Applications Days Sales Outstanding Related Terms
Ion Beam Applications Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Ion Beam Applications's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications Days Sales Outstanding Chart
IOBCF vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Ion Beam Applications's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's Days Sales Outstanding falls into.
Ion Beam Applications Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications (IOBCF) has a Days Sales Outstanding of 48.82 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ion Beam Applications and its competitors. This is 49% below median its historical median of 96.25. Over the past decade, Ion Beam Applications' Days Sales Outstanding has ranged from 49.30 to 140.00. According to the industry distribution chart, Ion Beam Applications ranks #225 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 27.8%.
Is Ion Beam Applications' Days Sales Outstanding too high?
Ion Beam Applications' current Days Sales Outstanding of 48.82 is 49% below median its 10-year median of 96.25. Over the past 10 years, this metric has ranged from a low of 49.30 to a high of 140.00. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.85. Ion Beam Applications' value of 48.82 is 25.9% below this industry median. Based on the distribution chart, Ion Beam Applications ranks #225 out of 810 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #225 out of 810 companies for Days Sales Outstanding. This puts Ion Beam Applications in the upper half of its industry. The industry median Days Sales Outstanding is 65.85. Ion Beam Applications' value of 48.82 is 25.9% below this benchmark. Historically, Ion Beam Applications' own Days Sales Outstanding has ranged from 49.30 to 140.00 over the past decade. While the company's 10-year median is 96.25 vs. the industry median of 65.85, Ion Beam Applications has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.85, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current Days Sales Outstanding of 48.82 is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current Days Sales Outstanding is 48.82, which is 49% below median its own 10-year median of 96.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.67, compared to a current price of $17.93 — trading 4% below its estimated fair value. The current Days Sales Outstanding is 48.82, which is 49% below median its 10-year median of 96.25 and 25.9% below the Medical Devices & Instruments industry median of 65.85. Ion Beam Applications' overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Days Sales Outstanding is 48.82 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued.
The current stock price of $17.93 is trading 4% below its estimated GF Value™ of $18.67.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
Days Sales Outstanding: 48.82 (49% below median its 10-year median of 96.25)
GF Value™: $18.67 vs. price of $17.93 (4% below fair value)
Industry Position: 25.9% below the Medical Devices & Instruments median (#225 of 810)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
